Search

Lei Yao

Examiner (ID: 12775, Phone: (571)272-3112 , Office: P/1642 )

Most Active Art Unit
1642
Art Unit(s)
1642
Total Applications
1328
Issued Applications
662
Pending Applications
127
Abandoned Applications
552

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 13677799 [patent_doc_number] => 20160377633 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-29 [patent_title] => BCL-2-LIKE PROTEIN 11 SRM/MRM ASSAY [patent_app_type] => utility [patent_app_number] => 15/262736 [patent_app_country] => US [patent_app_date] => 2016-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8581 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15262736 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/262736
Bcl-2-like protein 11 SRM/MRM assay Sep 11, 2016 Issued
Array ( [id] => 11381632 [patent_doc_number] => 20170007688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-12 [patent_title] => 'VACCINE DELIVERY SYSTEMS USING YEAST CELL WALL PARTICLES' [patent_app_type] => utility [patent_app_number] => 15/252999 [patent_app_country] => US [patent_app_date] => 2016-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12394 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15252999 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/252999
VACCINE DELIVERY SYSTEMS USING YEAST CELL WALL PARTICLES Aug 30, 2016 Abandoned
Array ( [id] => 11625923 [patent_doc_number] => 20170136108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-18 [patent_title] => 'NOVEL PEPTIDES, COMBINATION OF PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS' [patent_app_type] => utility [patent_app_number] => 15/249035 [patent_app_country] => US [patent_app_date] => 2016-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 72607 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15249035 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/249035
NOVEL PEPTIDES, COMBINATION OF PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS Aug 25, 2016 Abandoned
Array ( [id] => 13235019 [patent_doc_number] => 10130693 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-11-20 [patent_title] => Peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers [patent_app_type] => utility [patent_app_number] => 15/249121 [patent_app_country] => US [patent_app_date] => 2016-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 39 [patent_no_of_words] => 68647 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 198 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15249121 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/249121
Peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers Aug 25, 2016 Issued
Array ( [id] => 11627313 [patent_doc_number] => 20170137503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-18 [patent_title] => 'ANTAGONISTS OF BMP9, BMP10, ALK1 AND OTHER ALK1 LIGANDS, AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/245838 [patent_app_country] => US [patent_app_date] => 2016-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 23601 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15245838 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/245838
ANTAGONISTS OF BMP9, BMP10, ALK1 AND OTHER ALK1 LIGANDS, AND USES THEREOF Aug 23, 2016 Abandoned
Array ( [id] => 11704630 [patent_doc_number] => 20170173130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-22 [patent_title] => 'CANCER VACCINES AND VACCINATION METHODS' [patent_app_type] => utility [patent_app_number] => 15/227552 [patent_app_country] => US [patent_app_date] => 2016-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15089 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15227552 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/227552
Cancer vaccines and vaccination methods Aug 2, 2016 Issued
Array ( [id] => 13343665 [patent_doc_number] => 20180223372 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-09 [patent_title] => IDENTIFICATION OF PREDICTIVE BIOMARKERS ASSOCIATED WITH WNT PATHWAY INHIBITORS [patent_app_type] => utility [patent_app_number] => 15/749855 [patent_app_country] => US [patent_app_date] => 2016-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32297 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15749855 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/749855
IDENTIFICATION OF PREDICTIVE BIOMARKERS ASSOCIATED WITH WNT PATHWAY INHIBITORS Aug 2, 2016 Abandoned
Array ( [id] => 13326061 [patent_doc_number] => 20180214568 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-02 [patent_title] => ANTIBODY-DRUG CONJUGATES FOR TARGETING CD56-POSITIVE TUMORS [patent_app_type] => utility [patent_app_number] => 15/747620 [patent_app_country] => US [patent_app_date] => 2016-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20549 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15747620 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/747620
Antibody-drug conjugates for targeting CD56-positive tumors Jul 28, 2016 Issued
Array ( [id] => 17044963 [patent_doc_number] => 11098131 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-08-24 [patent_title] => Anti-EpCAM antibodies, compositions comprising anti-EpCAM antibodies and methods of making and using anti-EpCAM antibodies [patent_app_type] => utility [patent_app_number] => 15/748634 [patent_app_country] => US [patent_app_date] => 2016-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 47863 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15748634 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/748634
Anti-EpCAM antibodies, compositions comprising anti-EpCAM antibodies and methods of making and using anti-EpCAM antibodies Jul 27, 2016 Issued
Array ( [id] => 13329313 [patent_doc_number] => 20180216194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-02 [patent_title] => COMPOSITIONS AND METHODS FOR DETECTING PANCREATIC CANCER [patent_app_type] => utility [patent_app_number] => 15/747780 [patent_app_country] => US [patent_app_date] => 2016-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14405 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15747780 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/747780
COMPOSITIONS AND METHODS FOR DETECTING PANCREATIC CANCER Jul 24, 2016 Abandoned
Array ( [id] => 16822783 [patent_doc_number] => 20210138076 [patent_country] => US [patent_kind] => A2 [patent_issue_date] => 2021-05-13 [patent_title] => CELL-TARGETING MOLECULES COMPRISING SHIGA TOXIN A SUBUNIT EFFECTORS AND CD8+ T-CELL EPITOPES [patent_app_type] => utility [patent_app_number] => 15/747501 [patent_app_country] => US [patent_app_date] => 2016-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 66946 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -35 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15747501 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/747501
CELL-TARGETING MOLECULES COMPRISING SHIGA TOXIN A SUBUNIT EFFECTORS AND CD8+ T-CELL EPITOPES Jul 24, 2016 Abandoned
Array ( [id] => 16822783 [patent_doc_number] => 20210138076 [patent_country] => US [patent_kind] => A2 [patent_issue_date] => 2021-05-13 [patent_title] => CELL-TARGETING MOLECULES COMPRISING SHIGA TOXIN A SUBUNIT EFFECTORS AND CD8+ T-CELL EPITOPES [patent_app_type] => utility [patent_app_number] => 15/747501 [patent_app_country] => US [patent_app_date] => 2016-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 66946 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -35 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15747501 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/747501
CELL-TARGETING MOLECULES COMPRISING SHIGA TOXIN A SUBUNIT EFFECTORS AND CD8+ T-CELL EPITOPES Jul 24, 2016 Abandoned
Array ( [id] => 13311465 [patent_doc_number] => 20180207269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-26 [patent_title] => Methods of Treating CD166-Expressing Cancer [patent_app_type] => utility [patent_app_number] => 15/745582 [patent_app_country] => US [patent_app_date] => 2016-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17191 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15745582 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/745582
Methods of treating CD166-expressing cancer Jul 17, 2016 Issued
Array ( [id] => 14868073 [patent_doc_number] => 20190284278 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-19 [patent_title] => HUMANIZED OR CHIMERIC CD3 ANTIBODIES [patent_app_type] => utility [patent_app_number] => 15/744317 [patent_app_country] => US [patent_app_date] => 2016-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50782 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15744317 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/744317
Humanized or chimeric CD3 antibodies Jul 13, 2016 Issued
Array ( [id] => 13672721 [patent_doc_number] => 20160375094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-29 [patent_title] => TYROSINE-PHOSPHORYLATED WBP2, A NOVEL CANCER TARGET AND BIOMARKER [patent_app_type] => utility [patent_app_number] => 15/209538 [patent_app_country] => US [patent_app_date] => 2016-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19343 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15209538 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/209538
TYROSINE-PHOSPHORYLATED WBP2, A NOVEL CANCER TARGET AND BIOMARKER Jul 12, 2016 Abandoned
Array ( [id] => 12546312 [patent_doc_number] => 10011645 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-03 [patent_title] => Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers [patent_app_type] => utility [patent_app_number] => 15/202388 [patent_app_country] => US [patent_app_date] => 2016-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 31 [patent_no_of_words] => 51850 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15202388 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/202388
Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers Jul 4, 2016 Issued
Array ( [id] => 13781027 [patent_doc_number] => 20190004052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-03 [patent_title] => METHODS OF CHARACTERISING CANCER [patent_app_type] => utility [patent_app_number] => 15/737613 [patent_app_country] => US [patent_app_date] => 2016-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27546 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15737613 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/737613
METHODS OF CHARACTERISING CANCER Jun 19, 2016 Abandoned
Array ( [id] => 16290126 [patent_doc_number] => 10766962 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-09-08 [patent_title] => FZD7 specific antibodies and vaccines to treat cancer and control stem cell function [patent_app_type] => utility [patent_app_number] => 15/736646 [patent_app_country] => US [patent_app_date] => 2016-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 27 [patent_no_of_words] => 27350 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15736646 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/736646
FZD7 specific antibodies and vaccines to treat cancer and control stem cell function Jun 15, 2016 Issued
Array ( [id] => 11348927 [patent_doc_number] => 20160367667 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-22 [patent_title] => 'Compositions and Methods for Diagnosing and Treating Cancer' [patent_app_type] => utility [patent_app_number] => 15/167510 [patent_app_country] => US [patent_app_date] => 2016-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 34158 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15167510 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/167510
Compositions and Methods for Diagnosing and Treating Cancer May 26, 2016 Abandoned
Array ( [id] => 17783610 [patent_doc_number] => 11406715 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-09 [patent_title] => Methods of treating HER2-positive metastatic breast cancer [patent_app_type] => utility [patent_app_number] => 15/576593 [patent_app_country] => US [patent_app_date] => 2016-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 10790 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15576593 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/576593
Methods of treating HER2-positive metastatic breast cancer May 26, 2016 Issued
Menu